Bioventus Settles Securities Class Action for $15.25 Million

If you purchased or acquired Bioventus Class A common stock between February 11, 2021, and November 21, 2022, you may be eligible to claim a portion of a class action settlement.

Bioventus Inc. has agreed to pay $15,250,000 to settle a class action lawsuit for alleged violations of federal securities laws, specifically related to misleading statements and omissions about their financial reporting and internal controls.

Who can file a claim?

To be eligible to file a claim, you must have:

• Purchased or acquired Bioventus Class A common stock between February 11, 2021, and November 21, 2022
• Suffered loss

How much can class members get?

The settlement fund of $15,250,000 will be distributed among eligible class members. The exact amount each member will receive depends on several factors, including the number of valid claims submitted and the total number of shares involved.

The calculation for individual awards is based on the Recognized Loss Amount, which considers the difference between the artificial inflation of stock prices at purchase and sale times.

Here's how the calculation works:

• Calculate the difference in artificial inflation per share at purchase and sale dates.
• Subtract the sale price from the purchase price, excluding fees and commissions.

If the total of Recognized Claims exceeds the Net Settlement Fund, each claimant will receive a pro rata share. For example, if the Net Settlement Fund is $10,000,000 and the total Recognized Claims are $20,000,000, each claimant would receive 50% of their Recognized Claim.

What documentation is needed to file a claim?

Claimants need to provide proof of their transactions in Bioventus Class A common stock:

• Broker confirmations or stockbroker statements.
• Documentation of purchase and sale dates, prices, and number of shares.

How to claim an award

To claim an award, you must submit a Proof of Claim form online or by mail. You can file a claim online or send your completed form to:

Bioventus Securities Litigation

Claims Administrator

c/o A.B. Data, Ltd.

P.O. Box 173114

Milwaukee, WI 53217

Ensure your claim is postmarked or submitted online by December 2, 2024.

Payment methods

• Direct deposit to a bank account.
• Check mailed to the address provided in the claim form.

$15,250,000 settlement fund breakdown

• Attorneys' fees not to exceed 33% of the settlement amount.
• Litigation expenses up to $800,000.
• Administrative costs for claims processing and distribution.
• Compensation for the Lead Plaintiff, not exceeding $15,000.

Important dates

• Fairness Hearing: December 13, 2024
• Deadline to File a Claim: December 2, 2024

When is the Bioventus Securities Litigation payout date?

The payout date will be determined after the Fairness Hearing and once all claims have been processed. Please be patient as this process can take time.

Why was there a class action settlement?

The class action lawsuit was initiated due to alleged violations of federal securities laws by Bioventus. The company was accused of making misleading statements and omissions regarding their financial reporting and internal controls. To avoid the costs and risks associated with continued litigation, both parties agreed to settle the lawsuit.

What happens next?

Following the Fairness Hearing on December 13, 2024, the Court will decide whether to approve the settlement. If approved, the Claims Administrator will begin processing claims and distributing funds to eligible class members.